Recently Launched!
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Note: Free to use

[BMY] Bristol-Myers Squibb Co. - Time Machine

Data updated 2023-Oct-04 (Wednesday)
 


Quick Instructional video for this page. Collapse this after viewing by clicking How-to button above. Open in new tab 
Youtube Thumbnail

Note: Historical Detail for Bristol-Myers Squibb Co. as of 2023-Oct-04 (over 1 year ago) Market Close includes Performance (day & prior periods), Technical Indicators and Benchmarks. Use Related Links to view other info such as historical Financials and News for [NYSE:BMY] as available

Share       
Other Dates:  
Time machine widget shows Historical Detail for Bristol-Myers Squibb Co. on other dates (from 1998-Jan-02)
Historical Summary: 2023-Oct-04 Wednesday
 Open $57.10   High $57.34 +0.42%
 Close $56.73   Low $56.31 -1.38%
Volume 11.7 Million 1.05x Volatility 1.83%
Change $-0.49 -0.86%
Streak ↓ 4 days -2.43%

 20d SMA $58.88 -3.6%  50d SMA $60.44 -6.1%  100d SMA $62.53 -9.3%  200d SMA $66.45 -14.6%
 RSI 27  MACD -0.13  ADX 33.1  Stochastic Oscillator 11.8 13.1
 CCI -172.9  ATR 0.9  OBV 457 Million  Chaikin A/D 687 Million
 
Health Care Pharmaceuticals
Alerts: 52-week Low

Anomalies  AI

Anomaly Detection for Bristol-Myers Squibb Co. looks at key performance metrics relative to it's history (upto 10 years) for Bristol-Myers Squibb Co. to identify unusual levels for 2023-Oct-04:

  • 30-d Consistency at 33% is extraordinarily low. Subsequent performance over next 200 days in such cases averages +14.5% and is up 74% of the time
  • 5-d Consistency at 20% is extremely low
  • 100-d Downswing at +0.7% is extraordinarily low. Subsequent performance over next 200 days in such cases averages +21.4% and is up 80% of the time
  • Avg. 10-d Up performance at +0.5% is extraordinarily low. Subsequent performance over next 200 days in such cases averages +9.9% and is up 67% of the time
  • Avg. 20-d Up performance at +0.5% is extraordinarily low. Subsequent performance over next 20 days in such cases averages +1.7% and is up 68% of the time. Subsequent performance over next 200 days in such cases averages +14.3% and is up 73% of the time
    • ...
    Sign Up or Login to see more performance anomalies

    Anomaly Detection for Bristol-Myers Squibb Co. looks at key technical metrics relative to it's history (upto 10 years) for Bristol-Myers Squibb Co. to identify unusual levels for 2023-Oct-04:

  • CCI at -172.9 is extremely depressed. Subsequent performance over next 200 days in such cases averages +13.1% and is up 73% of the time
  • RSI at 27.3 is extraordinarily depressed. Subsequent performance over next 20 days in such cases averages +2.3% and is up 67% of the time. Subsequent performance over next 100 days in such cases averages +8.0% and is up 76% of the time
  • Fast Stochastic at 11.8 is extraordinarily depressed. Subsequent performance over next 200 days in such cases averages +12.7% and is up 74% of the time
  • % off 30d EMA at -4.5% is extraordinarily depressed. Subsequent performance over next 100 days in such cases averages +9.1% and is up 75% of the time
  • Slow Stochastic at 13.1 is extraordinarily depressed. Subsequent performance over next 200 days in such cases averages +12.9% and is up 75% of the time
    • ...
    Sign Up or Login to see more performance anomalies

     Anomaly Details
    Anomaly Detection uses Artificial Intelligence to find abnormal levels/metrics. Subsequent performance is aggregated for similar previous occurences in history and is called out if meaningful


    Choose view type

    Daily Performance for Bristol-Myers Squibb Co.. Click on candlesticks in Chart to show/hide summary for day or navigate to historical record (Time Machine functionality)



    Note: Performance over Key Timeperiods for Bristol-Myers Squibb Co. up to close of 2023-Oct-04 at $56.73
    Performance Benchmarks from 2023-Oct-04 for Bristol-Myers Squibb Co.:


    Related to Bristol-Myers Squibb Co.

    Information for Bristol-Myers Squibb Co.
      : Recent daily/monthly performance & benchmark comparison
      : Historical performance & related information using Time Machine Currently Viewing
      : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers
      : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
      : Investigate unusual recent performance & technicals with historical context using AI
      : Seasonal performance by calendar months
      : History of Dividend Yield
      : Popular Technical indicator trends (RSI, MACD etc.)
      : Contextualizing recent performance & technical levels into historical decile buckets
      : Dollar Cost Average (DCA) over time in your portfolio
      : Key Simple & Exponential Moving Averages
      : Insights from closest historical matches to recent performance using Artificial Intelligence
      : Insights from similar historical charts to recent chart using Artificial Intelligence
      News Stories : News stories on 2023-Oct-04 on Google
      SEC Reports : Quarterly reports around 2023-Oct-04 on SEC Edgar

    Compare Bristol-Myers Squibb Co. with other assets
      : Recent performance across covered assets
      : Prior & Subsequent performance across assets on a historical date
      : Technical indicator levels across covered assets
      : Seasonal performance by calendar months across covered assets
      : Performance Correlations with other assets
      : Volatility relative to the broad market
      : Visually compare/benchmark performance with other assets over time
      : Contrast with other assets over time in a side-by-side presentation
      : Health Care sector performance which includes Bristol-Myers Squibb Co.
      : Pharmaceuticals industry performance which includes Bristol-Myers Squibb Co.
    Analyze Bristol-Myers Squibb Co. in multiple dimensions using above resources. Other comparable assets include other stocks/etfs/crypto etc.